US500 rises 1% as vaccine rollout begins

US futures attempt to rebound from losing week

 US500 is rising almost 1% ahead of session opening after strong Friday's declines driven by concerns about Brexit. Now the upbeat news regarding Brexit negotiations together with the approval of Pfizer-BioNTech COVID Vaccine in the US and its subsequent rollout overshadowed concerns about further restrictions. Also statistically, the  Santa Claus rally starts in the middle of December which also improves the mood on the market.

US500 - the index bounced off the support at 3650 pts and launched today's session with a bullish price gap. However, it should be noted that, positioning is approaching an oversold level. Source: xStation5

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.